Program

Discover the program that will be offered at this upcoming XXXII International TTD Symposium on December 11st, 12nd, and 13th in Pamplona.

The Symposium will be held in English and Spanish, with simultaneous translation for both languages.

Download Book of Presentations

11 Dec
12 Dec
13 Dec
11 Dec
Wednesday
AUDITORIO
SATÉLITES
1st SESSION: ESOPHAGEAL-GASTRIC CANCER
12 Dec
AUDITORIO
10:45 - 12:15
Moderate
María Alsina
University Hospital of Navarra, Pamplona, Spain
Fernando Rivera
Marqués de Valdecilla University Hospital, Santander, Spain
10:45-11:05 | Perioperative treatment of esophageal-gastric adenocarcinoma.
Virginia Arrazubi
University Hospital of Navarra, Pamplona, Spain
11:05-11:25 | Challenges in biomarker determination in esophagogastric cancer and their clinical relevance.
Mar Iglesias
Hospital del Mar, Barcelona, Spain
11:25-11:45 | Therapeutic algorithm in gastric adenocarcinoma in 1st line: how to integrate different biomarkers.
Radka Obermannova
Masaryk Memorial Cancer Institute, Brno, Czech Republic
11:45-12:15 | Discussion
2nd SESSION. BILIARY TRACT TUMORS
12 Dec
AUDITORIO
12:45 - 14:15
Moderate
Teresa Macarulla
Vall d'Hebron University Hospital, Barcelona, Spain
Javier Sastre
San Carlos Clinical University Hospital, Madrid, Spain
12:45-13:05 | Neoadjuvant and adjuvant therapy in biliary tract cancer.
Jorge Adeva
12 de Octubre University Hospital, Madrid, Spain
13:05-13:25 | Precision medicine and immunotherapy in biliary tract tumors.
Ana Fernández Montes
University Hospital Complex of Ourense, Ourense, Spain
13:25-13:45 | Hepatocellular carcinoma: incorporating systemic treatment in earlier stages.
Ángela Lamarca
Jiménez Díaz Foundation, Madrid, Spain
13:45-14:15 | Discussion
3rd SESSION: PANCREAS AND NET
12 Dec
AUDITORIO
15:45 - 17:30
Moderate
Paula Jiménez Fonseca
Central University Hospital of Asturias, Oviedo, Spain
Alfredo Carrato
University of Alcalá de Henares, Madrid, Spain
15:45-16:15 | Treatment of resectable and borderline pancreatic cancer:
15:45-16:00 | Surgeon's point of view.
Luis Sabater
University Clinical Hospital of Valencia, Spain
16:00-16:15 | Oncologist's point of view.
José Ramón Rodríguez Mowbray
Virgen del Rocío University Hospital, Seville, Spain
16:15-16:30 | Future of pancreatic cancer: new drugs and IO.
Mairéad McNamara
The Christie NHS Foundation Trust, Manchester. United Kingdom
16:30-17:00 | Controversy 1st line in G2 pancreatic NETs.
SUMMARY

16:30-16:45 | Chemotherapy.

16:45-17:00 | Lutetium. 

16:30-16:45 | Chemotherapy.
Rocío García Carbonero
12 de Octubre University Hospital, Madrid, Spain
16:45-17:00 | Lutetium.
Jorge Hernando Cubero
Vall d'Hebron University Hospital, Barcelona, Spain
17:00-17:30 | Discussion.
KEYNOTE LECTURE
12 Dec
AUDITORIO
18:15 - 18:45
Moderate
Eduardo Díaz-Rubio
President of the Royal Academy of Medicine, Madrid, Spain
Ruth Vera
University Hospital of Navarra, Pamplona, Spain
18:15-18:20 | Introduction.
18:20-18:45 | TTD: Making innovation a reality for patients.
Enrique Aranda
Reina Sofía University Hospital, Córdoba, Spain
4th SESSION. LOCALIZED COLON CANCER
13 Dec
AUDITORIO
10:15 - 11:20
Moderate
Ramón Salazar
ICO. Duran i Reynals Hospital, Barcelona, Spain
Cristina Grávalos
12 de Octubre University Hospital, Madrid, Spain
10:15-10:30 | Neoadjuvant treatment in localized colon adenocarcinoma.
Eric Van Cutsem
University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven. Belgium
10:30-10:45 | Role of ctDNA in minimal residual disease
Clara Montagut
Hospital del Mar, Barcelona. Spain
10:45-11:00 | When the target is minimal residual disease: mRNA vaccines.
Elena Élez
Vall d'Hebron University Hospital, Barcelona, Spain
11:00-11:20 | Discussion
5th SESSION CLINICAL CASE: LOCALLY ADVANCED RECTAL CANCER FOR NEOADJUVANT THERAPY
13 Dec
AUDITORIO
11:20 - 12:20
Moderate
Auxiliadora Gómez España
Reina Sofía University Hospital, Córdoba, Spain
Encarna González Flores
Virgen de las Nieves University Hospital, Granada, Spain
11:20-11:25 | Presentation.
11:25-11:40 | Radiation oncology.
Eugeni Canals
ICO. Hospital Dr. Josep Trueta, Girona, Spain
11:40-11:55 | Medical oncology.
Mª José Safont
University General Hospital, Valencia, Spain
11:55-12:10 | Surgery.
Javier Suárez
University Hospital of Navarra, Pamplona, Spain
12:10-12:20 | Discussion
12:15 - 12:45
COFFEE BREAK
6th SESSION. METASTATIC COLON CANCER
13 Dec
AUDITORIO
12:45 - 14:35
Moderate
Pilar García Alfonso
Gregorio Marañón University Hospital, Madrid, Spain
Antonio Antón
Miguel Servet University Hospital, Zaragoza, Spain
12:45-13:05 | Early onset CRC.
David Páez
Santa Creu i Sant Pau University Hospital, Barcelona, Spain
13:05-13:25 | Role of hepatic metastases in MSS CRC.
Guillem Argilés
MSKCC Sloan Kettering Institute, New York, United States
13:25-13:45 | Precision medicine in metastatic CRC.
Andrea Sartore-Bianchi
Grande Ospedale Metropolitano Niguarda, Naples, Italy
13:45-14:05 | Immunotherapy in hypermutated metastatic CRC.
Julia Alcaide
Regional University Hospital and Virgen de la Victoria, Málaga, Spain
14:05-14:35 | Discussion
14:45 - 15:45
LUNCH
Virginia Arrazubi
Hospital Universitario de Navarra, Pamplona. España
1st SESSION: ESOPHAGEAL-GASTRIC CANCER
12 Dec
AUDITORIO
10:45 - 12:15
Intervenes in
10:45-11:05 | Perioperative treatment of esophageal-gastric adenocarcinoma.
Mar Iglesias
Hospital del Mar, Barcelona. España
1st SESSION: ESOPHAGEAL-GASTRIC CANCER
12 Dec
AUDITORIO
10:45 - 12:15
Intervenes in
11:05-11:25 | Challenges in biomarker determination in esophagogastric cancer and their clinical relevance.
Radka Obermannova
Masaryk Memorial Cancer Institute, Brno. República Checa
1st SESSION: ESOPHAGEAL-GASTRIC CANCER
12 Dec
AUDITORIO
10:45 - 12:15
Intervenes in
11:25-11:45 | Therapeutic algorithm in gastric adenocarcinoma in 1st line: how to integrate different biomarkers.
Jorge Adeva
Hospital Universitario 12 de Octubre, Madrid. España

Facultativo especialista en Oncología médica en el Hospital Universitario 12 de octubre, Madrid (España)

Miembro de la Unidad de Cáncer Digestivo con foco en tumores hepatobiliopancreáticos: asistencia a pacientes con colangiocarcinoma/cáncer de vesícula biliar, hepatocarcinoma y cáncer de páncreas.

Miembro de la Unidad de Cáncer Familiar consejería sobre riesgo de cáncer hereditario. Asesoramiento a pacientes oncológicos y/o familiares. 

Coordinador del Comité multidisciplinar de tumores hepatobiliopancreáticos del Hospital Universitario 12 de octubre. 

Miembro del Grupo de Trabajo Pancreatobiliar del Grupo Español TTD (Tratamiento de tumores digestivos).

Miembro de la ENSCCA (Red Europea para el Estudio del Colangiocarcinoma). 

Amplia experiencia en el campo de la investigación clínica en el área de tumores digestivos, habiendo participado como IP/SI en múltiples ensayos clínicos desarrollados a nivel nacional e internacional.

Miembro del Comité de Ética del Hospital Universitario 12 de octubre para la evaluación de proyectos clínicos de investigación médica.

2nd SESSION. BILIARY TRACT TUMORS
12 Dec
AUDITORIO
12:45 - 14:15
Intervenes in
12:45-13:05 | Neoadjuvant and adjuvant therapy in biliary tract cancer.
Ana Fernández Montes
Complejo Hospitalario Universitario de Ourense, Ourense. España
2nd SESSION. BILIARY TRACT TUMORS
12 Dec
AUDITORIO
12:45 - 14:15
Intervenes in
13:05-13:25 | Precision medicine and immunotherapy in biliary tract tumors.
Ángela Lamarca
Fundación Jiménez Díaz, Madrid. España
2nd SESSION. BILIARY TRACT TUMORS
12 Dec
AUDITORIO
12:45 - 14:15
Intervenes in
13:25-13:45 | Hepatocellular carcinoma: incorporating systemic treatment in earlier stages.
Luis Sabater
Hospital Clínico Universitario de Valencia, Valencia. España
3rd SESSION: PANCREAS AND NET
12 Dec
AUDITORIO
15:45 - 17:30
Intervenes in
15:45-16:00 | Surgeon's point of view.
José Ramón Rodríguez Mowbray
Hospital Universitario Virgen del Rocío, Sevilla. España
3rd SESSION: PANCREAS AND NET
12 Dec
AUDITORIO
15:45 - 17:30
Intervenes in
16:00-16:15 | Oncologist's point of view.
Mairéad McNamara
The Christie NHS Foundation Trust. Manchester, Reino Unido
3rd SESSION: PANCREAS AND NET
12 Dec
AUDITORIO
15:45 - 17:30
Intervenes in
16:15-16:30 | Future of pancreatic cancer: new drugs and IO.
Rocío García Carbonero
Hospital Universitario 12 de Octubre, Madrid. España
3rd SESSION: PANCREAS AND NET
12 Dec
AUDITORIO
15:45 - 17:30
Intervenes in
16:30-16:45 | Chemotherapy.
Jorge Hernando Cubero
Hospital Universitario Vall d’Hebrón, Barcelona. España
3rd SESSION: PANCREAS AND NET
12 Dec
AUDITORIO
15:45 - 17:30
Intervenes in
16:45-17:00 | Lutetium.
Enrique Aranda
Hospital Universitario Reina Sofía, Córdoba. España
KEYNOTE LECTURE
12 Dec
AUDITORIO
18:15 - 18:45
Intervenes in
18:20-18:45 | TTD: Making innovation a reality for patients.
Eric Van Cutsem
University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven. Bélgica
4th SESSION. LOCALIZED COLON CANCER
13 Dec
AUDITORIO
10:15 - 11:20
Intervenes in
10:15-10:30 | Neoadjuvant treatment in localized colon adenocarcinoma.
Clara Montagut
Hospital del Mar, Barcelona. España
4th SESSION. LOCALIZED COLON CANCER
13 Dec
AUDITORIO
10:15 - 11:20
Intervenes in
10:30-10:45 | Role of ctDNA in minimal residual disease
Elena Élez
Hospital Universitario Vall d’Hebrón, Barcelona. España
4th SESSION. LOCALIZED COLON CANCER
13 Dec
AUDITORIO
10:15 - 11:20
Intervenes in
10:45-11:00 | When the target is minimal residual disease: mRNA vaccines.
Eugeni Canals
ICO. Hospital Dr. Josep Trueta, Girona. España
5th SESSION CLINICAL CASE: LOCALLY ADVANCED RECTAL CANCER FOR NEOADJUVANT THERAPY
13 Dec
AUDITORIO
11:20 - 12:20
Intervenes in
11:25-11:40 | Radiation oncology.
Mª José Safont
Hospital General Universitario, Valencia. España
5th SESSION CLINICAL CASE: LOCALLY ADVANCED RECTAL CANCER FOR NEOADJUVANT THERAPY
13 Dec
AUDITORIO
11:20 - 12:20
Intervenes in
11:40-11:55 | Medical oncology.
Javier Suárez
Hospital Universitario de Navarra, Pamplona. España
5th SESSION CLINICAL CASE: LOCALLY ADVANCED RECTAL CANCER FOR NEOADJUVANT THERAPY
13 Dec
AUDITORIO
11:20 - 12:20
Intervenes in
11:55-12:10 | Surgery.
David Páez
Hospital Universitario Santa Creu i Sant Pau, Barcelona. España
6th SESSION. METASTATIC COLON CANCER
13 Dec
AUDITORIO
12:45 - 14:35
Intervenes in
12:45-13:05 | Early onset CRC.
Guillem Argilés
MSKCC Sloan Kettering Institute, Nueva York. Estados Unidos
6th SESSION. METASTATIC COLON CANCER
13 Dec
AUDITORIO
12:45 - 14:35
Intervenes in
13:05-13:25 | Role of hepatic metastases in MSS CRC.
Andrea Sartore-Bianchi
Grande Ospedale Metropolitano Niguarda, Nápoles. Italia
6th SESSION. METASTATIC COLON CANCER
13 Dec
AUDITORIO
12:45 - 14:35
Intervenes in
13:25-13:45 | Precision medicine in metastatic CRC.
Julia Alcaide
Hospital Regional Universitario y Virgen de la Victoria, Málaga, España
6th SESSION. METASTATIC COLON CANCER
13 Dec
AUDITORIO
12:45 - 14:35
Intervenes in
13:45-14:05 | Immunotherapy in hypermutated metastatic CRC.
María Alsina
Hospital Universitario de Navarra, Pamplona. España
1st SESSION: ESOPHAGEAL-GASTRIC CANCER
12 Dec
AUDITORIO
10:45 - 12:15
Moderate
Fernando Rivera
Hospital Universitario Marqués de Valdecilla, Santander. España
1st SESSION: ESOPHAGEAL-GASTRIC CANCER
12 Dec
AUDITORIO
10:45 - 12:15
Moderate
Teresa Macarulla
Hospital Universitario Vall d’Hebrón, Barcelona. España
2nd SESSION. BILIARY TRACT TUMORS
12 Dec
AUDITORIO
12:45 - 14:15
Moderate
Javier Sastre
Hospital Universitario Clínico San Carlos, Madrid. España
2nd SESSION. BILIARY TRACT TUMORS
12 Dec
AUDITORIO
12:45 - 14:15
Moderate
Paula Jiménez Fonseca
Hospital Universitario Central de Asturias, Oviedo, España
3rd SESSION: PANCREAS AND NET
12 Dec
AUDITORIO
15:45 - 17:30
Moderate
Alfredo Carrato
Universidad de Alcalá de Henares, Madrid. España
3rd SESSION: PANCREAS AND NET
12 Dec
AUDITORIO
15:45 - 17:30
Moderate
Eduardo Díaz-Rubio
Presidente de la Real Academia de Medicina, Madrid. España
KEYNOTE LECTURE
12 Dec
AUDITORIO
18:15 - 18:45
Moderate
Ruth Vera
Hospital Universitario de Navarra, Pamplona. España
KEYNOTE LECTURE
12 Dec
AUDITORIO
18:15 - 18:45
Moderate
Ramón Salazar
ICO. Hospital Duran i Reynals, Barcelona, España
4th SESSION. LOCALIZED COLON CANCER
13 Dec
AUDITORIO
10:15 - 11:20
Moderate
Cristina Grávalos
Hospital Universitario 12 de Octubre, Madrid. España
4th SESSION. LOCALIZED COLON CANCER
13 Dec
AUDITORIO
10:15 - 11:20
Moderate
Auxiliadora Gómez España
Hospital Universitario Reina Sofía, Córdoba. España
5th SESSION CLINICAL CASE: LOCALLY ADVANCED RECTAL CANCER FOR NEOADJUVANT THERAPY
13 Dec
AUDITORIO
11:20 - 12:20
Moderate
Encarna González Flores
Hospital Universitario Virgen de las Nieves, Granada. España
5th SESSION CLINICAL CASE: LOCALLY ADVANCED RECTAL CANCER FOR NEOADJUVANT THERAPY
13 Dec
AUDITORIO
11:20 - 12:20
Moderate
Pilar García Alfonso
Hospital Universitario Gregorio Marañón, Madrid. España
6th SESSION. METASTATIC COLON CANCER
13 Dec
AUDITORIO
12:45 - 14:35
Moderate
Antonio Antón
Hospital Universitario Miguel Servet, Zaragoza. España
6th SESSION. METASTATIC COLON CANCER
13 Dec
AUDITORIO
12:45 - 14:35
Moderate